Exploring the latest insights in Prostate cancer diagnostics together with BIOMEDICA CRO 🔬🎗
A recent meta-analysis conducted by researchers at Brigham and Women’s Hospital proposes that a combination of MRI findings of the prostate with blood prostate-specific antigen (PSA) density could help doctors and patients avoid unnecessary prostate biopsies.
Based on data from over 36,000 patients, the analysis aimed to validate earlier findings in a more diverse sample. As it turned out, patients with a PI-RADS score below 4 and a PSAD under 0.10 ng/ml2 may not require biopsies. By adhering to specific PI-RADS and PSAD cutoffs, physicians could potentially forego 50% of biopsies while missing only 5% of significant cancers or skip 30% and miss just 3%.
According to Adam Kibel, MD, Chair of the Department of Urology and study co-author, these findings suggest that in some instances, men can be safely monitored with testing instead of opting for biopsies.
Please find more information about this research on the JAMA Network Open website, article “Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer.”
In light of these developments, we at BIOMEDICA CRO want to highlight our readiness to assist with further studies by providing high-quality human biological specimens and associated clinical data from individuals with various cancer types, including Prostate cancer, for further investigation.
Order blood & other biosamples at BIOMEDICA CRO and discover the worth of high-quality biospecimens and clinical data 🩸
BIOMEDICA CRO has been a global provider of various human biological samples since 2017. We offer prospective and retrospective collections of various human biospecimen types and associated clinical data.
Our own network of 50+ direct contracts with hospitals in Ukraine allows us to participate in the research of a wide range of diseases. We can provide support for the following cancer research projects:
- Prostate cancer;
- Lung cancer;
- Breast cancer;
- Colorectal cancer (CRC);
- Kidney cancer;
- Head & Neck cancer;
- Thyroid cancer;
- Uterine/Endometrial/Cervical cancer, etc.
In our standard collection process, we have the capacity to obtain up to 50 ml of whole blood from each donor, which can then be processed into various biosample types such as plasma, buffy coat, serum, PBMC, and more. Besides blood, we can also obtain other biofluids for research, such as saliva, urine, stool, and more.
In addition to biosamples, we can also provide extensive clinical data for each case, including general donor information, diagnostic methods, CT/MRI conclusions, laboratory test results, and additional relevant details. This detailed sample and donor data can be provided using our standard Data Manifest templates or customized according to your preferred format, including eCRFs, Google forms, or other specified templates.
We are fully prepared to comply with the specific Inclusion and Exclusion criteria of our Customers, as well as sample processing and aliquoting schemes.
📩 Please email us to start our collaboration and order biospecimens at office@biomedica-cro.com.
BIOMEDICA CRO team is fully committed to supporting you in every step of your journey. We would be delighted to discuss your project in detail, address any inquiries you may have, and tailor our support to meet your research goals.
🌐 Clicking here, you can explore our extensive range of banked biological samples.
🚀 Follow us on LinkedIn to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of human biospecimen procurement. Together, let’s drive innovation and make remarkable discoveries.
